印度尼西亚：中国COVID-19疫苗试验志愿者感染病毒

https://www.aa.com.tr/en/asia-pacific/indonesia-chinese-vaccine-trial-volunteer-gets-virus/1970177
原文
------------------------------------------------------------
A clinical trial volunteer for a Chinese COVID-19 vaccine candidate in Indonesia tested positive for the virus, said the trial team leader on Friday.

The vaccine is developed by a Chinese company, Sinovac Biotech, and imported to the country by the state-owned Bio Farma.

Kusnandi Rusmil, the head of the trial and research team from Padjadjaran University, said in a statement that the infected volunteer has been put in isolation under strict supervision.

"After nine days, the volunteer’s condition seems to be good," said Rusmil, without specifying the volunteer’s gender.

He said the volunteer, after receiving the first injection for the trial, traveled out of town.

“The volunteer was declared healthy upon returning from the trip and then received the second injection,” said Rusmil.

However, he added, due to their travel history, the volunteer was required to take COVID-19 test by the local health authority and tested positive for the virus.

Rusmil said he was unable to confirm whether the volunteer was injected with a potential vaccine or a placebo.

“As we conduct the trials under blind observer principle, we cannot identify who gets the vaccine and who gets the placebo,” he added.

Volunteers who were injected with placebo would be compared to those who were injected with the potential vaccine to determine its capability to build immunity.

Rusmil went on to say that the volunteers’ immunity against the virus would be formed after the second injection.

"Clinical trial volunteers will still have their health monitored for six months after the last injection," he said.

The team is conducting Phase 3 of the clinical trials, which started in early August to last six months.

At least 450 volunteers have been injected with a potential vaccine or placebo.

* Writing by Rhany Chairunissa Rufinaldo from Anadolu Agency's Indonesian language services in Jakarta.
------------------------------------------------------------

谷哥机翻
------------------------------------------------------------
该研究小组负责人周五说，一名在印度尼西亚的中国候选COVID-19疫苗的临床试验志愿者对该病毒呈阳性反应。

该疫苗由中国公司Sinovac Biotech开发，并由国有Bio Farma进口到中国。

Padjadjaran大学试验与研究小组负责人Kusnandi Rusmil在一份声明中说，受感染的志愿者已被严格隔离。

Rusmil说：“经过9天，志愿者的状况似乎很好。”他没有说明志愿者的性别。

他说，志愿者在接受第一次注射后，便出城了。

Rusmil说：“志愿者从旅行中回来后被宣布健康，然后接受了第二次注射。”

但是，他补充说，由于他们的旅行经历，志愿者被要求接受当地卫生部门的COVID-19测试，并对该病毒进行阳性检测。

Rusmil说，他无法确认志愿者是否被注射了潜在的疫苗或安慰剂。

他补充说：“由于我们是在盲观察者原则下进行试验，因此我们无法确定谁接种了疫苗，谁接种了安慰剂。”

将注射安慰剂的志愿者与注射潜在疫苗的志愿者进行比较，以确定其增强免疫力的能力。

Rusmil继续说，志愿者对病毒的免疫力将在第二次注射后形成。

他说：“临床试验志愿者在最后一次注射后仍将接受六个月的健康监测。”

该小组正在进行8月初开始的为期六个月的临床试验的第三阶段。

至少有450名志愿者被注射了潜在的疫苗或安慰剂。
------------------------------------------------------------

记得前阵子非洲某中矿企员工好像也有接种又阳性的案例....